Onasemnogene Abeparvovec-xioi Gene-Replacement Therapy for Spinal Muscular Atrophy Type 1: Pulmonary and Ventilatory Findings from the Pivotal Phase 3 US Study (STR1VE)
R. Shell
◽
J.W. Day
◽
C.A. Chiriboga
◽
T.O. Crawford
◽
B.T. Darras
◽
...
J. Day
◽
C. Chiriboga
◽
T. Crawford
◽
B. Darras
◽
R. Finkel
◽
...
John W. Day
◽
Claudia A. Chiriboga
◽
Thomas O. Crawford
◽
Basil T. Darras
◽
Richard S. Finkel
◽
...
R. Shell
◽
J.W. Day
◽
C. Chiriboga
◽
T.O. Crawford
◽
B.T. Darras
◽
...
2019 ◽
Vol 405
◽
pp. 277-278
E. Mercuri
◽
G. Baranello
◽
J.W. Day
◽
C. Bruno
◽
S. Corti
◽
...
Francesco Muntoni
◽
Giovanni Baranello
◽
Claudio Bruno
◽
Stefania Corti
◽
Riccardo Masson
◽
...
R Shell
◽
JW Day
◽
CA Chiriboga
◽
TO Crawford
◽
BT Darras
◽
...
O. Dabbous
◽
D.M. Sproule
◽
D.E. Feltner
◽
M. Droege
◽
F. Khan
◽
...
2018 ◽
Vol 54
(2)
◽
pp. 179-185
◽
Samiah Al‐Zaidy
◽
A. Simon Pickard
◽
Kavitha Kotha
◽
Lindsay N. Alfano
◽
Linda Lowes
◽
...
O. Dabbous
◽
D.M. Sproule
◽
D.E. Feltner
◽
F.G. Ogrinc
◽
M. Menier
◽
...
Close
Export Citation Format
Close
Share Document
Close